1. Home
  2. OPRX vs EDAP Comparison

OPRX vs EDAP Comparison

Compare OPRX & EDAP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo OptimizeRx Corporation

OPRX

OptimizeRx Corporation

HOLD

Current Price

$5.07

Market Cap

120.1M

ML Signal

HOLD

Logo EDAP TMS S.A.

EDAP

EDAP TMS S.A.

HOLD

Current Price

$4.22

Market Cap

128.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
OPRX
EDAP
Founded
2006
1979
Country
United States
France
Employees
N/A
N/A
Industry
Business Services
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
120.1M
128.9M
IPO Year
2008
1998

Fundamental Metrics

Financial Performance
Metric
OPRX
EDAP
Price
$5.07
$4.22
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
6
1
Target Price
$16.67
$10.00
AVG Volume (30 Days)
506.3K
38.8K
Earning Date
05-12-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
124.55
N/A
EPS
N/A
N/A
Revenue
$109,429,000.00
$70,527,000.00
Revenue This Year
$3.88
N/A
Revenue Next Year
$8.34
$6.13
P/E Ratio
N/A
N/A
Revenue Growth
18.78
1.63
52 Week Low
$4.57
$1.21
52 Week High
$22.25
$5.05

Technical Indicators

Market Signals
Indicator
OPRX
EDAP
Relative Strength Index (RSI) 38.92 57.85
Support Level $4.57 $3.18
Resistance Level $7.23 $4.38
Average True Range (ATR) 0.36 0.26
MACD -0.04 0.00
Stochastic Oscillator 27.00 49.20

Price Performance

Historical Comparison
OPRX
EDAP

About OPRX OptimizeRx Corporation

OptimizeRx Corp is engaged in the healthcare market in the United States. is a digital healthcare technology company that connects over two million HCPs and millions of their patients through an intelligent technology platform embedded within a proprietary omnichannel network. OptimizeRx helps life sciences organizations engage and support their customers through its combined HCP and DTC marketing strategies.

About EDAP EDAP TMS S.A.

Edap TMS SA is a holding company operating in three divisions namely, HIFU (High-Intensity Focused Ultrasound), ESWL (Extracorporeal ShockWave Lithotripsy), and Distribution. The HIFU division develops, manufactures, and markets devices for the invasive destruction of certain types of tumors using HIFU technology. It markets three HIFU devices: the Ablatherm, Ablatherm Fusion, and the Focal One. The ESWL division is engaged in the manufacturing, marketing, and servicing of its installed base of Sonolith range of lithotripters. The Distribution division markets products that are complementary to its globalized activity such as lasers, micro-ultrasound systems, and other medical products from third parties. Its geographical segments are Asia, France, United States, and Others.

Share on Social Networks: